Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on X Ray Contrast Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1154689A reveals a safer, high-yield process for X-ray contrast agent intermediates using tertiary amines and specific hydrocarbon solvents.
Advanced preparation of 5-chloroacetamide-N,N'-bi(2,3-dihydroxyl propyl)-2,4,6-triiodo-1,3-benzenedicarboxamide via optimized acyl chloride pathway for cost-effective contrast media manufacturing.
Advanced preparation method for Iopromide using novel intermediates to eliminate bismer byproducts. Ensures high yield and purity for contrast agent manufacturing.